India focus on China’s US$1trn healthcare market
Study on how to access Chinese market
India has released a study is underway on “Enhancing Indian Exports of Pharmaceutical products to China”, as the Chinese healthcare sector is expected to balloon to US$1 trillion in 2020 from US$357 billion in 2011.
The study under the Market Access Initiative Scheme (MAI) will help the Indian pharma industry to evolve appropriate and focused strategy for entry of the Indian generic drugs in China.
The study examines the health care market, pharmaceutical market the distribution system, procurement and bidding process and the regulatory landscape in China.
The study also gives recommendations on how to access the Chinese market.
China remains among the world’s most attractive markets, and by far the fastest-growing of all the large emerging ones from pharmaceuticals to medical products to consumer health.
The study has been done by IMS Health team which worked with PHARMEXCIL and Industry stakeholders. fii-news.com